WallStreetZenWallStreetZen

NASDAQ: LNTH
Lantheus Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LNTH

Based on 6 analysts offering 12 month price targets for Lantheus Holdings Inc

Min Forecast
$61.00+3.25%
Avg Forecast
$74.17+25.54%
Max Forecast
$84.00+42.18%

Should I buy or sell LNTH stock?

Based on 6 analysts offering ratings for Lantheus Holdings Inc.

Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LNTH's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates LNTH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LNTH stock forecasts and price targets.

LNTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-10
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-09-16
lockedlocked$00.00+00.00%2025-09-15
lockedlocked$00.00+00.00%2025-08-07
Mizuho
Top 8%
93
BuyMaintains$70.00+18.48%2025-08-07

1 of 1

Forecast return on equity

Is LNTH forecast to generate an efficient return?

Company
48.67%
Industry
284.26%
Market
230.71%
LNTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LNTH forecast to generate an efficient return on assets?

Company
23.93%
Industry
156.01%
LNTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LNTH earnings per share forecast

What is LNTH's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$5.70+132.64%
Avg 2 year Forecast
$5.65+130.51%
Avg 3 year Forecast
$6.77+176.25%
LNTH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LNTH revenue forecast

What is LNTH's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$1.5B+0.53%
Avg 2 year Forecast
$1.6B+1.77%
Avg 3 year Forecast
$1.8B+14.95%
LNTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LNTH earnings growth forecast

How is LNTH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
38.85%
Industry
364.7%
Market
43.12%
LNTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LNTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LNTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LNTH revenue growth forecast

How is LNTH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
4.1%
Industry
131.96%
Market
25.64%
LNTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LNTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LNTH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
LNTH$59.08$74.17+25.54%Buy
AMRX$12.31$13.50+9.67%Strong Buy
INDV$33.60$32.50-3.27%Strong Buy
ALKS$28.90$44.00+52.25%Strong Buy
PBH$59.93$77.00+28.48%Buy
View Top Pharmaceutical Stocks

Lantheus Holdings Stock Forecast FAQ

Is Lantheus Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: LNTH) stock is to Buy LNTH stock.

Out of 6 analysts, 2 (33.33%) are recommending LNTH as a Strong Buy, 2 (33.33%) are recommending LNTH as a Buy, 2 (33.33%) are recommending LNTH as a Hold, 0 (0%) are recommending LNTH as a Sell, and 0 (0%) are recommending LNTH as a Strong Sell.

If you're new to stock investing, here's how to buy Lantheus Holdings stock.

What is LNTH's earnings growth forecast for 2025-2027?

(NASDAQ: LNTH) Lantheus Holdings's forecast annual earnings growth rate of 38.85% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 364.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.12%.

Lantheus Holdings's earnings in 2025 is $167,681,000.On average, 16 Wall Street analysts forecast LNTH's earnings for 2025 to be $377,963,878, with the lowest LNTH earnings forecast at $357,420,489, and the highest LNTH earnings forecast at $401,053,639. On average, 15 Wall Street analysts forecast LNTH's earnings for 2026 to be $374,502,403, with the lowest LNTH earnings forecast at $287,236,102, and the highest LNTH earnings forecast at $423,334,397.

In 2027, LNTH is forecast to generate $448,811,383 in earnings, with the lowest earnings forecast at $317,779,307 and the highest earnings forecast at $552,145,028.

What is LNTH's revenue growth forecast for 2025-2027?

(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 4.1% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 131.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.

Lantheus Holdings's revenue in 2025 is $1,525,933,000.On average, 16 Wall Street analysts forecast LNTH's revenue for 2025 to be $101,722,268,986, with the lowest LNTH revenue forecast at $96,947,820,898, and the highest LNTH revenue forecast at $105,634,663,947. On average, 15 Wall Street analysts forecast LNTH's revenue for 2026 to be $102,982,192,787, with the lowest LNTH revenue forecast at $93,101,737,716, and the highest LNTH revenue forecast at $111,403,788,720.

In 2027, LNTH is forecast to generate $116,310,860,366 in revenue, with the lowest revenue forecast at $94,560,596,854 and the highest revenue forecast at $129,971,086,840.

What is LNTH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: LNTH) forecast ROA is 23.93%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 156.01%.

What is LNTH's Price Target?

According to 6 Wall Street analysts that have issued a 1 year LNTH price target, the average LNTH price target is $74.17, with the highest LNTH stock price forecast at $84.00 and the lowest LNTH stock price forecast at $61.00.

On average, Wall Street analysts predict that Lantheus Holdings's share price could reach $74.17 by Nov 10, 2026. The average Lantheus Holdings stock price prediction forecasts a potential upside of 25.54% from the current LNTH share price of $59.08.

What is LNTH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: LNTH) Lantheus Holdings's current Earnings Per Share (EPS) is $2.45. On average, analysts forecast that LNTH's EPS will be $5.70 for 2025, with the lowest EPS forecast at $5.39, and the highest EPS forecast at $6.05. On average, analysts forecast that LNTH's EPS will be $5.65 for 2026, with the lowest EPS forecast at $4.33, and the highest EPS forecast at $6.38. In 2027, LNTH's EPS is forecast to hit $6.77 (min: $4.79, max: $8.33).

What is LNTH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: LNTH) forecast ROE is 48.67%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.